IC
ELV icon

Inscription Capital’s Elevance Health ELV Stock Holding History

Inscription Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$600K Buy
1,552
+239
+18% +$88.6K 0.05% 339
2026
Q1 		$384K Buy
+1,313
New +$432K 0.04% 427
2021
Q3 		– Sell
-2,520
Closed -$962K – 259
2021
Q2 		$962K Buy
+2,520
New +$963K 0.11% 136

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Inscription Capital's ELV Position: Q2 2026 in Review

Inscription Capital increased its Elevance Health (ELV) stake by 18% in Q2 2026, buying an estimated $88.6K and bringing the position to 1,552 shares worth $600K. The position accounts for 0.05% of the portfolio, ranked #339.

Inscription Capital first reported a position in ELV in Q2 2021 and has held it in 3 quarters since. The position peaked at $962K in Q2 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Inscription Capital held 1,552 shares of Elevance Health worth $600K as of Q2 2026.
  • Inscription Capital bought 239 Elevance Health shares in Q2 2026, an estimated $88.6K.
  • Elevance Health made up 0.05% of Inscription Capital's portfolio in Q2 2026, its #339 holding.
  • Inscription Capital first reported a position in Elevance Health in Q2 2021 and has held it in 3 quarters since.
  • Inscription Capital's Elevance Health position peaked at $962K in Q2 2021.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.